Clinical Trial Update: Evaluation of Diabetic Effects on Clinical Outcomes After Sirolimus-Eluting Stents in the AsIAN Population [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how diabetes affects clinical outcomes after sirolimus-eluting stents in an Asian population. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED